Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Clofarabine in Refractory acute myeloid leukemia: NCT07156435 Clinical Landscape Report 2026
15 October 2026
NCT07156435 clinical landscape for Refractory acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
HSK-47388 in Plaque psoriasis: NCT07158268 Clinical Landscape Report 2026
15 October 2026
NCT07158268 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fenebrutinib in Multiple sclerosis relapse: NCT07161258 Clinical Landscape Report 2026
15 October 2026
NCT07161258 clinical landscape for Multiple sclerosis relapse: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Autologous CD19-targeting CAR T cells(Hebei Senlangbio Biotechnology) in Idiopathic Inflammatory Myopathies: NCT07161193 Clinical Landscape Report 2026
15 October 2026
NCT07161193 clinical landscape for Idiopathic Inflammatory Myopathies: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
9 min read
Tacrolimus in Dermatitis, Atopic: NCT07162896 Clinical Landscape Report 2026
15 October 2026
NCT07162896 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Venetoclax in Acute Myeloid Leukemia: NCT07163793 Clinical Landscape Report 2026
15 October 2026
NCT07163793 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
TRIV-509 in Dermatitis, Atopic: NCT07167758 Clinical Landscape Report 2026
15 October 2026
NCT07167758 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
XY0206 in Acute Myeloid Leukemia with FLT3/ITD Mutation: NCT07162116 Clinical Landscape Report 2026
15 October 2026
NCT07162116 clinical landscape for Acute Myeloid Leukemia with FLT3/ITD Mutation: endpoints, sponsor, phase, geography, readouts, asset context and developme…
9 min read
Methotrexate Sodium in Psoriasis of scalp: NCT07169019 Clinical Landscape Report 2026
15 October 2026
NCT07169019 clinical landscape for Psoriasis of scalp: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Camrelizumab in Uterine Cervical Cancer: NCT07167160 Clinical Landscape Report 2026
15 October 2026
NCT07167160 clinical landscape for Uterine Cervical Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Anti-BCMA CAR-T(Institute of Hematology & Blood Diseases Hospital) in Multiple Myeloma: NCT07169500 Clinical Landscape Report 2026
15 October 2026
NCT07169500 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Carboplatin in Locally Advanced Cervical Carcinoma: NCT07168200 Clinical Landscape Report 2026
15 October 2026
NCT07168200 clinical landscape for Locally Advanced Cervical Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white s…